Stefan Glück, MD, PhD, is a Sylvester Professor in the Department of Medicine, Miller School of Medicine at the University of Miami in Miami, Florida. He is a medical oncologist as well as the Assistant Director, Sylvester Comprehensive Cancer Center / Clinical Trials at the University of Miami/Sylvester Comprehensive Cancer Center in Miami, Florida. In addition, he is the Associate Division Chief of Hematology/Oncology for Clinical Affairs. Furthermore, from 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute. Dr. Glück was recently presented the America’s Top Oncologists 2008 award from Consumers’ Research Council of America; he also received the Best Doctors in America honor in 2006 and 2007, which is a special merit earned on the basis of a nationwide survey of more than 1 million votes from his peers. This award was warranted after less than 3 years of working in the United States. Before his move to Miami, Dr Glück was Director, Southern Alberta Breast Cancer Program at the Tom Baker Cancer Center, a Professor in the departments of oncology, medicine, pharmacology, and therapeutics at the University of Calgary in Alberta, Canada, and Deputy Head, Department of Oncology at the University of Calgary. Dr Glück completed his medical studies at the Free University of West Berlin, Germany. The internship in Berlin was followed by residency in internal medicine and fellowship in hematology at the Heinrich Heine Universität in Düsseldorf, Germany, and a medical oncology and bone marrow transplant fellowship at the Princess Margaret Hospital, University of Toronto in Canada.

His interest is in clinical trials in breast cancer and he is a PI of 24 clinical studies in breast cancer in Miami, and investigator in numerous scientific, translational projects. Dr Glück is a member of such prestigious professional organizations, as the American Society of Clinical Oncology, the European Society for Medical Oncology, the American and European Association of Cancer Research, and the International Association for Breast Cancer Research. He is a reviewer for the following journals: Journal of Clinical Oncology, European Journal of Cancer, Journal of Hematotherapy, Lancet Oncology, Lancet, Breast Cancer Research, Critical Reviews in Oncology & Hematology, and Treatment, Oncologist, Oncology, and Journal of Neoplasia, The Breast Journal, Clinical Breast Cancer, and Bio Med Central. He is Medical Co-Editor of Stem Cell Research, Chronicles of Cancer Therapy, and American Journal of Therapy. He has authored or co-authored more than 150 articles. In addition, Dr Glück has written or co-written a number of book chapters and numerous journal abstracts, and he has presented more than 300 papers at national and international meetings.